✦ LIBER ✦

Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix

✍ Scribed by Ioulia Chatzistamou; Andrew V. Schally; Karoly Szepeshazi; Kate Groot; Francine Hebert; Jose M. Arencibia

Book ID: 117466969
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 177 KB
Volume: 171
Category: Article
ISSN: 0304-3835
DOI: 10.1016/s0304-3835(01)00543-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the growth of caki-I human

Inhibition of the growth of caki-I human renal adenocarcinoma in Vivo by luteinizing hormone-releasing hormone antagonist cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II

✍ Andreas Jungwirth; Andrew V. Schally; Gabor Halmos; Kate Groot; Karoly Szepeshaz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

## Background: Metastatic or recurrent renal cell carcinoma (rcc) is a therapeutic challenge because it is resistant to chemotherapy and external radiotherapy. no uniformly effective therapeutic agents are available for the management of patients with rcc. hormones and growth factors may play a rol

Luteinizing hormone-releasing hormone an

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

✍ Jungwirth, Andreas; Galvan, Georg; Pinski, Jacek; Halmos, Gabor; Szepeshazi, Kar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Background: Hormones like bombesin (bn)/gastrin-releasing peptide (grp) and luteinizing hormone-releasing hormone (lh-rh) and growth factors such as epidermal growth factor (egf) might be involved in the relapse of prostate cancer under androgen ablation therapy. interference with receptors for

Inhibition of growth of androgen-indepen

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II

✍ A. Jungwirth; J. Pinski; G. Galvan; G. Halmos; K. Szepeshazi; R.Z. Gai; K. Groot 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 966 KB

Mechanisms of inhibition of human benign

Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix

✍ Agnieszka Siejka; Andrew V. Schally; Norman L. Block; Nektarios Barabutis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

Inhibitory effect of bombesin/gastrin-re

Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone—releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice

✍ Tetsu Yano; Jacek Pinski; Karoly Szepeshazi; Gabor Halmos; Sinisa Radulovic; Kat 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 940 KB

Novel antagonists of growth hormone-rele

Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers

✍ Anna Klukovits; Andrew V. Schally; Luca Szalontay; Irving Vidaurre; Andrea Papad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 877 KB

## Abstract ## BACKGROUND: Antagonists of growth hormone‐releasing hormone (GHRH) inhibit the proliferation of various human cancer cell lines and experimental tumors by mechanisms that include direct action on GHRH receptors in cancer cells. ## METHODS: In this study, the effects of newly synth